Jeffrey K. Kerns

1.6k total citations
20 papers, 978 citations indexed

About

Jeffrey K. Kerns is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Jeffrey K. Kerns has authored 20 papers receiving a total of 978 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Organic Chemistry and 6 papers in Oncology. Recurrent topics in Jeffrey K. Kerns's work include Cytokine Signaling Pathways and Interactions (5 papers), Genomics, phytochemicals, and oxidative stress (4 papers) and NF-κB Signaling Pathways (4 papers). Jeffrey K. Kerns is often cited by papers focused on Cytokine Signaling Pathways and Interactions (5 papers), Genomics, phytochemicals, and oxidative stress (4 papers) and NF-κB Signaling Pathways (4 papers). Jeffrey K. Kerns collaborates with scholars based in United States, United Kingdom and China. Jeffrey K. Kerns's co-authors include James F. Callahan, A. James Wilson, Brian I. Carr, Christopher J. Moody, Yuji Nishikawa, Craig S. Wilcox, Thomas G. Davies, Noriaki Murase, Linghang Zhuang and Caroline J. Richardson and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and PLoS ONE.

In The Last Decade

Jeffrey K. Kerns

20 papers receiving 963 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jeffrey K. Kerns United States	15	646	358	126	114	81	20	978
Eric Van Quaquebeke Belgium	8	705 1.1×	228 0.6×	136 1.1×	74 0.6×	76 0.9×	21	1.1k
Seung Wook Ham South Korea	18	523 0.8×	317 0.9×	75 0.6×	35 0.3×	156 1.9×	57	1.0k
Jeffrey A. Robl United States	23	1.0k 1.6×	668 1.9×	182 1.4×	134 1.2×	37 0.5×	61	1.9k
Sumit J. Shah United States	15	448 0.7×	136 0.4×	130 1.0×	139 1.2×	58 0.7×	23	872
Samuel Chackalamannil United States	24	504 0.8×	848 2.4×	68 0.5×	89 0.8×	35 0.4×	75	1.7k
Xanthippi Alexi Greece	20	430 0.7×	157 0.4×	105 0.8×	91 0.8×	50 0.6×	31	820
Usman Ghani Saudi Arabia	13	365 0.6×	236 0.7×	88 0.7×	68 0.6×	18 0.2×	24	838
Bruce G. Szczepankiewicz United States	19	904 1.4×	386 1.1×	155 1.2×	69 0.6×	148 1.8×	32	1.4k
Chris A. Veale United States	18	364 0.6×	641 1.8×	79 0.6×	61 0.5×	42 0.5×	28	1.1k

Countries citing papers authored by Jeffrey K. Kerns

Since Specialization

Citations

This map shows the geographic impact of Jeffrey K. Kerns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey K. Kerns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey K. Kerns more than expected).

Fields of papers citing papers by Jeffrey K. Kerns

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey K. Kerns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey K. Kerns. The network helps show where Jeffrey K. Kerns may publish in the future.

Co-authorship network of co-authors of Jeffrey K. Kerns

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey K. Kerns. A scholar is included among the top collaborators of Jeffrey K. Kerns based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey K. Kerns. Jeffrey K. Kerns is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Norton, David L., William G. Bonnette, James F. Callahan, et al.. (2021). Fragment-Guided Discovery of Pyrazole Carboxylic Acid Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2 Related Factor 2 (KEAP1:NRF2) Protein−Protein Interaction. Journal of Medicinal Chemistry. 64(21). 15949–15972. 23 indexed citations

2.

Yonchuk, John, Joseph P. Foley, Brian Bolognese, et al.. (2017). Characterization of the Potent, Selective Nrf2 Activator, 3-(Pyridin-3-Ylsulfonyl)-5-(Trifluoromethyl)-2H-Chromen-2-One, in Cellular and In Vivo Models of Pulmonary Oxidative Stress. Journal of Pharmacology and Experimental Therapeutics. 363(1). 114–125. 18 indexed citations

3.

Cleasby, Anne, Jeff Yon, Philip J. Day, et al.. (2014). Structure of the BTB Domain of Keap1 and Its Interaction with the Triterpenoid Antagonist CDDO. PLoS ONE. 9(6). e98896–e98896. 202 indexed citations

4.

Wilson, A. James, Jeffrey K. Kerns, James F. Callahan, & Christopher J. Moody. (2013). Keap Calm, and Carry on Covalently. Journal of Medicinal Chemistry. 56(19). 7463–7476. 146 indexed citations

5.

Miller, David D., Paul Bamborough, J.A. Christopher, et al.. (2011). 3,5-Disubstituted-indole-7-carboxamides: The discovery of a novel series of potent, selective inhibitors of IKK-β. Bioorganic & Medicinal Chemistry Letters. 21(8). 2255–2258. 13 indexed citations

6.

Kerns, Jeffrey K., Hong Nie, William E. Bondinell, et al.. (2011). Azepanone-based inhibitors of human cathepsin S: Optimization of selectivity via the P2 substituent. Bioorganic & Medicinal Chemistry Letters. 21(15). 4409–4415. 10 indexed citations

7.

Bamborough, Paul, James F. Callahan, J.A. Christopher, et al.. (2009). Progress Towards the Development of Anti-Inflammatory Inhibitors of IKKβ. Current Topics in Medicinal Chemistry. 9(7). 623–639. 21 indexed citations

8.

Smith, Amos B., Qiyan Lin, Victoria A. Doughty, et al.. (2009). Spongipyran synthetic studies. Total synthesis of (+)-spongistatin 2. Tetrahedron. 65(33). 6470–6488. 22 indexed citations

9.

Christopher, J.A., Paul Bamborough, Catherine M. Alder, et al.. (2009). Discovery of 6-Aryl-7-alkoxyisoquinoline Inhibitors of IκB Kinase-β (IKK-β). Journal of Medicinal Chemistry. 52(9). 3098–3102. 29 indexed citations

10.

Busch‐Petersen, Jakob, et al.. (2008). Efficient and Scalable Synthesisof 3,5,7-Trisubstituted 1H-Indazolesas Potent IKK2 Inhibitors. Synlett. 2008(20). 3216–3220. 6 indexed citations

11.

Wang, Yonghui, Jakob Busch‐Petersen, Feng Wang, et al.. (2007). 3-Arylamino-2H-1,2,4-benzothiadiazin-5-ol 1,1-dioxides as novel and selective CXCR2 antagonists. Bioorganic & Medicinal Chemistry Letters. 17(14). 3864–3867. 25 indexed citations

12.

Christopher, J.A., Paul Bamborough, Geoffrey J. Cutler, et al.. (2007). The discovery of 2-amino-3,5-diarylbenzamide inhibitors of IKK-α and IKK-β kinases. Bioorganic & Medicinal Chemistry Letters. 17(14). 3972–3977. 53 indexed citations

13.

Yan, Hongxing, Jeffrey K. Kerns, Qi Jin, et al.. (2005). A Highly Convergent Synthesis of 2‐Phenyl Quinoline as Dual Antagonists for NK2 and NK3 Receptors. Synthetic Communications. 35(24). 3105–3112. 11 indexed citations

14.

Smith, Amos B., Qiyan Lin, Victoria A. Doughty, et al.. (2001). The Spongistatins: Architecturally Complex Natural Products—Part Two: Synthesis of the C(29–51) Subunit, Fragment Assembly, and Final Elaboration to (+)-Spongistatin 2. Angewandte Chemie. 113(1). 202–205. 17 indexed citations

15.

Smith, Amos B., Qiyan Lin, Victoria A. Doughty, et al.. (2001). The Spongistatins: Architecturally Complex Natural Products-Part Two: Synthesis of the C(29-51) Subunit, Fragment Assembly, and Final Elaboration to (+)-Spongistatin 2. Angewandte Chemie International Edition. 40(1). 196–199. 86 indexed citations

16.

Smith, Amos B., Qiyan Lin, Victoria A. Doughty, et al.. (2001). The Spongistatins: Architecturally Complex Natural Products—Part Two: Synthesis of the C(29–51) Subunit, Fragment Assembly, and Final Elaboration to (+)-Spongistatin 2. Angewandte Chemie International Edition. 40(1). 196–199. 1 indexed citations

17.

Smith, Amos B., Qiyan Lin, Victoria A. Doughty, et al.. (2001). The Spongistatins: Architecturally Complex Natural Products-Part Two: Synthesis of the C(29-51) Subunit, Fragment Assembly, and Final Elaboration to (+)-Spongistatin 2 Financial support was provided by the National Institutes of Health (National Cancer Institute) through Grant CA-70329, a NIH Postdoctoral Fellowship to C.S.B., a Japan Society for Promotion of Science Fellowship to N.M., and a Royal Society Fulbright Fellowship to V.A.D. We also thank the Daiichi Pharmaceutical Co., Ltd, and the Tanabe Seiyaku Co., Ltd for financial support. Finally we thank Dr George T. Furst, Dr. Patrick J. Carroll, and Dr. Rakesh Kohli of the University of Pennsylvania Spectroscopic Service Center for assistance in securing and interpreting high-field NMR spectra, X-ray crystal structures, and mass spectra, respectively.. PubMed. 40(1). 196–199. 23 indexed citations

18.

Tamura, Kenji, Eileen C. Southwick, Jeffrey K. Kerns, et al.. (2000). Cdc25 inhibition and cell cycle arrest by a synthetic thioalkyl vitamin K analogue.. PubMed. 60(5). 1317–25. 93 indexed citations

19.

Nishikawa, Yuji, Ziqiu Wang, Jeffrey K. Kerns, Craig S. Wilcox, & Brian I. Carr. (1999). Inhibition of Hepatoma Cell Growth in Vitro by Arylating and Non-arylating K Vitamin Analogs. Journal of Biological Chemistry. 274(49). 34803–34810. 45 indexed citations

20.

Nishikawa, Yuji, Brian I. Carr, Meifang Wang, et al.. (1995). Growth Inhibition of Hepatoma Cells Induced by Vitamin K and Its Analogs. Journal of Biological Chemistry. 270(47). 28304–28310. 134 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact